NCT05147090View on ClinicalTrials.gov

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

PHASE4RecruitingINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

January 2, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Hepatitis bNAFLDCirrhosisFibrosis, LiverEmpagliflozinSGLT2 Inhibitors
Interventions
DRUG

Empagliflozin 10 MG

Empagliflozin 10mg daily

DRUG

Placebo pills

Identical in appearance to empagliflozin 10mg daily

Trial Locations (1)

852

RECRUITING

The University of Hong Kong/Queen Mary Hospital, Hong Kong

All Listed Sponsors
collaborator

Research Grant Council

UNKNOWN

lead

The University of Hong Kong

OTHER